Buprenorphine tapering schedule and illicit opioid use. (Q35147170)

6 August 2017

title

Buprenorphine tapering schedule and illicit opioid use. (English)

1 reference

6 August 2017

0 references

Walter Ling

1

1 reference

6 August 2017

Maureen Hillhouse

2

1 reference

6 August 2017

Catherine Domier

3

1 reference

6 August 2017

Geetha Doraimani

4

1 reference

6 August 2017

Jeremy Hunter

5

1 reference

6 August 2017

Christie Thomas

6

1 reference

6 August 2017

Jessica Jenkins

7

1 reference

6 August 2017

Albert Hasson

8

1 reference

6 August 2017

Jeffrey Annon

9

1 reference

6 August 2017

Andrew Saxon

10

1 reference

6 August 2017

Jeffrey Selzer

11

1 reference

6 August 2017

Joshua Boverman

12

1 reference

6 August 2017

Richard Bilangi

13

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

6 August 2017

1 reference

6 August 2017

volume

104

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

256-265

1 reference

Office-based buprenorphine treatment for opioid-dependent patients

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

The Clinical Opiate Withdrawal Scale (COWS).

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Naltrexone shortened opioid detoxification with buprenorphine

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Clinical pharmacology of buprenorphine: ceiling effects at high doses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

A controlled trial of buprenorphine treatment for opioid dependence

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Comparison of buprenorphine and methadone in the treatment of opioid dependence

13 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02455.X

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02455.X

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2008.02455.X

Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Short-term buprenorphine maintenance: treatment outcome

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Gradual dose taper following chronic buprenorphine

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150159

A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification

27 September 2018

1 reference

12 December 2020

Acute administration of buprenorphine in humans: partial agonist and blockade effects

1 reference

12 December 2020

Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet

1 reference

12 December 2020

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts

1 reference

12 December 2020

10.1111/J.1360-0443.2008.02455.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference